|
1
|
Sperber AD and Dekel R: Irritable bowel
syndrome and co-morbid gastrointestinal and extra-gastrointestinal
functional syndromes. J Neurogastroenterol Motil. 16:113–119. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berstad A, Undseth R, Lind R and Valeur J:
Functional bowel symptoms, fibromyalgia and fatigue: A food-induced
triad? Scand J Gastroenterol. 47:914–919. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vandvik PO, Lydersen S and Farup PG:
Prevalence, comorbidity and impact of irritable bowel syndrome in
Norway. Scand J Gastroenterol. 41:650–656. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim SE and Chang L: Overlap between
functional GI disorders and other functional syndromes: What are
the underlying mechanisms? Neurogastroenterol Motil. 24:895–913.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valeur J, Morken MH, Norin E, Midtvedt T
and Berstad A: Carbohydrate intolerance in patients with
self-reported food hypersensitivity: Comparison of lactulose and
glucose. Scand J Gastroenterol. 44:1416–1423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Undseth R, Berstad A, Kløw NE, Arnljot K,
Moi KS and Valeur J: Abnormal accumulation of intestinal fluid
following ingestion of an unabsorbable carbohydrate in patients
with irritable bowel syndrome: An MRI study. Neurogastroenterol
Motil. 26:1686–1693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le Nevé B, Posserud I, Böhn L, Guyonnet D,
Rondeau P, Tillisch K, Naliboff B, Mayer EA and Simrén M: A
combined nutrient and lactulose challenge test allows symptom-based
clustering of patients with irritable bowel syndrome. Am J
Gastroenterol. 108:786–795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Le Nevé B, Brazeilles R, Derrien M, Tap J,
Guyonnet D, Ohman L, Törnblom H and Simrén M: Lactulose challenge
determines visceral sensitivity and severity of symptoms in
patients with irritable bowel syndrome. Clin Gastroenterol Hepatol.
14:226-233.e1–e3. 2016.
|
|
9
|
Ohman L and Simrén M: Pathogenesis of IBS:
Role of inflammation, immunity and neuroimmune interactions. Nat
Rev Gastroenterol Hepatol. 7:163–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wilcz-Villega E, McClean S and O'Sullivan
M: Reduced E-cadherin expression is associated with abdominal pain
and symptom duration in a study of alternating and diarrhea
predominant IBS. Neurogastroenterol Motil. 26:316–325. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Longstreth GF, Thompson WG, Chey WD,
Houghton LA, Mearin F and Spiller RC: Functional bowel disorders.
Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Francis CY, Morris J and Whorwell PJ: The
irritable bowel severity scoring system: A simple method of
monitoring irritable bowel syndrome and its progress. Aliment
Pharmacol Ther. 11:395–402. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fisk JD, Ritvo PG, Ross L, Haase DA,
Marrie TJ and Schlech WF: Measuring the functional impact of
fatigue: Initial validation of the fatigue impact scale. Clin
Infect Dis. 18:(Suppl 1). S79–S83. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aaron LA, Burke MM and Buchwald D:
Overlapping conditions among patients with chronic fatigue
syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern
Med. 160:221–227. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trøseid M, Nowak P, Nyström J, Lindkvist
A, Abdurahman S and Sonnerborg A: Elevated plasma levels of
lipopolysaccharide and high mobility group box-1 protein are
associated with high viral load in HIV-1 infection: Reduction by
2-year antiretroviral therapy. AIDS. 24:1733–1737. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gajda AM and Storch J: Enterocyte fatty
acid-binding proteins (FABPs): Different functions of liver and
intestinal FABPs in the intestine. Prostaglandins Leukot Essent
Fatty Acids. 93:9–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sacchettini JC, Hauft SM, Van Camp SL,
Cistola DP and Gordon JI: Developmental and structural studies of
an intracellular lipid binding protein expressed in the ileal
epithelium. J Biol Chem. 265:19199–19207. 1990.PubMed/NCBI
|
|
18
|
Bottasso Arias NM, García M, Bondar C,
Guzman L, Redondo A, Chopita N, Córsico B and Chirdo FG: Expression
pattern of fatty acid binding proteins in celiac disease
Enteropathy. Mediators Inflamm. 2015:7385632015.PubMed/NCBI
|
|
19
|
Bingold TM, Franck K, Holzer K,
Zacharowski K, Bechstein WO, Wissing H and Scheller B: Intestinal
fatty acid binding protein: A sensitive marker in abdominal surgery
and abdominal infection. Surg Infect (Larchmt). 16:247–253. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
González-Castro AM, Martínez C,
Salvo-Romero E, Fortea M, Pardo-Camacho C, Pérez-Berezo T,
Alonso-Cotoner C, Santos J and Vicario M: Mucosal pathobiology and
molecular signature of epithelial barrier dysfunction in the small
intestine in Irritable Bowel Syndrome. J Gastroenterol Hepatol.
18–Apr;2016.(Epub ahead of print). View Article : Google Scholar
|
|
21
|
Arslan G, Kahrs GE, Lind R, Frøyland L,
Florvaag E and Berstad A: Patients with subjective food
hypersensitivity: The value of analyzing intestinal permeability
and inflammation markers in gut lavage fluid. Digestion. 70:26–35.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berstad A, Arslan G and Folvik G:
Relationship between intestinal permeability and calprotectin
concentration in gut lavage fluid. Scand J Gastroenterol. 35:64–69.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lau E, Marques C, Pestana D, Santoalha M,
Carvalho D, Freitas P and Calhau C: The role of I-FABP as a
biomarker of intestinal barrier dysfunction driven by gut
microbiota changes in obesity. Nutr Metab (Lond). 13:312016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cani PD, Amar J, Iglesias MA, Poggi M,
Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et
al: Metabolic endotoxemia initiates obesity and insulin resistance.
Diabetes. 56:1761–1772. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Layé S, Parnet P, Goujon E and Dantzer R:
Peripheral administration of lipopolysaccharide induces the
expression of cytokine transcripts in the brain and pituitary of
mice. Brain Res Mol Brain Res. 27:157–162. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dlugosz A, Nowak P, D'Amato M, Mohammadian
KG, Nyström J, Abdurahman S and Lindberg G: Increased serum levels
of lipopolysaccharide and antiflagellin antibodies in patients with
diarrhea-predominant irritable bowel syndrome. Neurogastroenterol
Motil. 27:1747–1754. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maes M, Mihaylova I and Leunis JC:
Increased serum IgA and IgM against LPS of enterobacteria in
chronic fatigue syndrome (CFS): Indication for the involvement of
gram-negative enterobacteria in the etiology of CFS and for the
presence of an increased gut-intestinal permeability. J Affect
Disord. 99:237–240. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han CJ and Yang GS: Fatigue in irritable
bowel syndrome: A systematic review and meta-analysis of pooled
frequency and severity of Fatigue. Asian Nurs Res (Korean Soc Nurs
Sci). 10:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tülübaş F, Oran M, Mete R, Turan F, Yilmaz
A, Yildiz ZD and Gürel A: Investigation of serum macrophage
migration inhibitor factor and monocyte chemotactic protein-1
levels in irritable bowel syndrome. Turk J Med Sci. 44:967–971.
2014. View Article : Google Scholar : PubMed/NCBI
|
